Latest Forum Topics /
IX Biopharma
Last:0.355
+0.01
|
 Post Reply
|
|
iX Biopharma
|
|||||
|
ReminiserJr
Member |
30-Aug-2020 20:35
|
||||
|
x 0
x 0 Alert Admin |
Ix Biopharma's Xativa supply agreement with Cannatrek anticipates Australian market alone expected to grow from S$0.05 billion 2020 to S$1.billion in 2024. Wafesil with Yiling Pharmaceutical China estimates next 5 years sales to be within range of S140.7 - S$160.7 million. Tomorrow opening likely up 1 to 4 cents (4 - 18%) ..don't want high fluctuations. Be an investor and buy into the vision of the company and not simply a trader. | ||||
| Useful To Me Not Useful To Me | |||||
|
98mich98
Master |
30-Aug-2020 20:20
|
||||
|
x 0
x 0 Alert Admin |
When they open up china , europe n US mkt. Will.see good revenues. Most of the research costs were already done. Wait n see.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
ReminiserJr
Member |
30-Aug-2020 19:32
|
||||
|
x 0
x 0 Alert Admin |
IX Biopharma's cannibidiol (CBD) product Xatria miracle story :- A girl Charlotte Figi, miraculously recovered from Dravet Syndrome, which is a rare retractable epilepsy, through the use of CBD oil. Charlotte went from having 300 grand Mal seizure a week to 1 or 2 mild seizure per month. Importantly no eide effects were reported after her use of CBD oil for 3 years. Market size projected to reach S$66.3 billion by 2025 from S$13.8 billion. Now ready to out licence to commercialize their products. DODD. | ||||
| Useful To Me Not Useful To Me | |||||
|
ReminiserJr
Member |
30-Aug-2020 18:47
|
||||
|
x 0
x 0 Alert Admin |
Five years ago placements shares between 6.7¢ and 12.5¢ shareholders include Yeo Chung San (6.6m), prominent investor Alan Wang&rsquo s Asdew Acquisitions (4m) and orthopedist Ang Kian Chuan (3.9m). The offer of 65.5m new shares (64.5m placement and 1m public offer), representing 11.1% of enlarged share capital, was 1.4x subscribed. Shares surged to a high of $0.64 on debut, a 39% above its IPO price of $0.46. Net proceeds of $27.6m from the IPO in 2015 was mainly used to fund clinical trials for product development. iX Biopharma specialises in the development and commercialisation of pharmaceutical therapies for pain management (Xativa in Australia) and male erectile dysfunction (Wafesil in China). Many more countries with confirmed patents awaiting commercialization and converting many eons of clinical trials into profits. Now bearing fruits...reaping your harvest...bountiful in many seasons to come. This is proverbial goose that lays your golden egg. | ||||
| Useful To Me Not Useful To Me | |||||
|
shadow11
Veteran |
30-Aug-2020 15:52
|
||||
|
x 0
x 0 Alert Admin |
Tell that to ug health-care placee
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
ReminiserJr
Member |
30-Aug-2020 15:49
|
||||
|
x 0
x 0 Alert Admin |
S$ 0.57 million earned in the fourth quarter based on IX Biopharma's 2 best selling products, Xativa and Wafersil accounting for 56% of the entire year 2020 revenue. Announcement made only end April and delay on new wafer plant production, curtailing sales and production by 600%. Taking into consideration group may need 1 month to get all counters and products in place within half to one month...sales only started mid April or at best beginning May 2020. Conservatively say selling only for 2 months till end if financial year June, with potential upside of 6 folds if no disruption to supplies. Most sold out within a month. Projected sales at 0.57million for only 2 months x 6 (12 months in a year)= S$34.2 million annual projected sales. If production fully in place, means x 6 folds = S$205.2 million. IPO shares at 65.5million (S$64.5 placement and 1 million public offer). EPS from 0.522 to S$3.13 (Imagine the sky with 3xPE ratio factored in). Stock investment is buying into the future prospect of the company. Currently, Biolodics at 0.38, Hyphens Pharma at 0.425 and even new kid on the block, Vicplas at 0.6. We have to make our OWN judgement, as cannot forecast BB's mind. Have a fulfilling weekend and wait for opening bell on Monday, 31st August 2020. | ||||
| Useful To Me Not Useful To Me | |||||
|
guards80
Supreme |
30-Aug-2020 15:04
|
||||
|
x 0
x 0 Alert Admin |
Wait for BB to cook up tmr let see
|
||||
| Useful To Me Not Useful To Me | |||||
|
look@bright
Elite |
30-Aug-2020 14:43
|
||||
|
x 0
x 0 Alert Admin |
Overall is a positive result for IX | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
98mich98
Master |
30-Aug-2020 13:45
|
||||
|
x 0
x 0 Alert Admin |
Which investors and funds will want to invest if the share pricr will drop below placements.
They already know the projected sales figures in june. 23c plus some upside in 6mths target. 30c shb be well supported after placement. NAV 36c with 10m injected. |
||||
| Useful To Me Not Useful To Me | |||||
|
98mich98
Master |
30-Aug-2020 13:41
|
||||
|
x 0
x 0 Alert Admin |
The placement was agreed and presented to invesotrs on june. So the investors will have some deeper info on hows the company going to do in futures with 6 folds production and sales increase.
I doubt the share pricr will be affected since it has been hovering ard 270-30. Some contras and shortists may wnt to sell down. I think new investors will support the price abv thier placement 23. Monday pennies rallies. All huat ah |
||||
| Useful To Me Not Useful To Me | |||||
|
churnw
Elite |
30-Aug-2020 13:14
|
||||
|
x 0
x 0 Alert Admin |
The result is positive and moving on the right side.
Based on slower COVID case in the region ... Aust , China and Singapore. Road to recovery is strong . |
||||
| Useful To Me Not Useful To Me | |||||
|
ReminiserJr
Member |
30-Aug-2020 11:01
|
||||
|
x 0
x 0 Alert Admin |
Not sure what price to set for matching on Monday. 0.33 0.35 or 0.4? Or even below last friday closing? From Smallsmall- and why I also buy to keep - iX Biopharma's patented WaferiX dissolvable product 1. Wafesil (Generic Viagra) is the first sub-lingual sildenafil product to receive regulatory approval globally. 2. WaferMine, a sublingual Ketamin product for pain management, claimed to be non-addictive (unlike opioids), is in advanced stage of clinical trials. To date, the Group has successfully registered 21 products with the Therapeutic Goods Australia with several products in the pipeline. Revenues from its nutraceuticals division which sells products in WaferiX format have just started coming in. This includes LumeniX for skin lightening and anti-aging and WafeRest for the promotion of sleep. From Huat 888:- Initial stock of LumeniX has sold out on both of Entity&rsquo s Tmall Global and JD Worldwide stores, and RestoriX is sold out on its JD Worldwide store, ahead of initial forecasts provided by its marketing agencies in China. LumeniX, is a novel sublingual wafer containing glutathione, the master of all antioxidants, formulated using iX Biopharma&rsquo s WaferiX drug delivery technology. LumeniX is designed to promote skin fairness, while helping the body to build a stronger immunity against viral infections like Covid, while boosting energy levels and vitality Ms Eva Tan, Director of Corporate and Commercial Strategy of iX Biopharma said: &ldquo We are very encouraged to have received such strong support the Chinese consumers are purchasing LumeniX not only because of LumeniX&rsquo s ability to boost the body&rsquo s immune system, which can help to protect against viral infections. The quick take-up of LumeniX and RestoriX, reflects the strong demand by Chinese consumers for innovative, functional nutraceuticals that characterise the Entity line of products.&rdquo Both stores will be restocked shortly to meet the growing demand. At the rate of the initial response, plus the growth projected by the agencies, Entity will hit its wafer production capacity very soon. The iX Biopharma group has invested in new equipment which will significantly increase its wafer production capacity. | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
ReminiserJr
Member |
30-Aug-2020 10:36
|
||||
|
x 0
x 0 Alert Admin |
Read someone that share price outlook depending on RSI for 7 weeks is 0.288 and 24 weeks 0.284, lowest at 0.26 and highest at 0.33. Other factors on investor confidence and environment. Placement of shares only 1 million to public during the IPO in 2015. Rest of S$65.5 million in hands of private investors. Sane fir the next tranche of placement to raise S$10million for marketing at 0.23 cents. When news cane out only drop 10% to 0.28. If anyone knows how to calculate the RSI formula to see above or below 5, then we can tell if over bought or oversold and whether to hold or sell. Main rule of thumb is usually sell on news but not sure what price to sell, even though we saw some IPS shares drop with stellar results - reason bring share price was high the friday before and already factor in the results. For IX last Friday closed was 0.275 (Already factor in the S$10 million placement at 0.23 but not results yet) weaker than the 7 days and 24 days average. Layman wisdom like mine would be to sell based on the facts but my hearts wants to keep. Any advice from the SGX veterans? | ||||
| Useful To Me Not Useful To Me | |||||
|
guards80
Supreme |
30-Aug-2020 01:06
|
||||
|
x 0
x 0 Alert Admin |
ya lor $10.2m leh not $10k :P
|
||||
| Useful To Me Not Useful To Me | |||||
|
JessTrang
Veteran |
30-Aug-2020 00:30
|
||||
|
x 0
x 0 Alert Admin |
Yes, agreed. But i think worst come to worst the drop is at a minimum to moderate. If the company is so jiatlat, why would there be people go dump the money into company in this period.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Pavillion78
Member |
29-Aug-2020 23:36
|
||||
|
x 0
x 0 Alert Admin |
Agreed must have confident I think monday will raise.lol
|
||||
| Useful To Me Not Useful To Me | |||||
|
guards80
Supreme |
29-Aug-2020 23:31
|
||||
|
x 0
x 0 Alert Admin |
Is up to market sentiment. Good result also drop like crazy. Recently result for ips damn good u see deop like nobody. If IX good result monday sentiment no good also cannot go up one. If result no good. When market sentiment damn good. Also will go up. So up to market sentiment on monday
|
||||
| Useful To Me Not Useful To Me | |||||
|
JessTrang
Veteran |
29-Aug-2020 20:16
|
||||
|
x 0
x 0 Alert Admin |
After the placement news released, it stayed within the range .26- 0.29 for nearly one month. Wonder why will it drop to .23 when a positive results was released. Do your due deligence and anticapte the next 6 months of performance of this company. This company is not glove counter but they can overcome this climate and lure new investors with theirs results and vision. I think thats speak volume.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Charanko
Senior |
29-Aug-2020 20:10
|
||||
|
x 0
x 0 Alert Admin |
siao liao monday drop so much?
|
||||
| Useful To Me Not Useful To Me | |||||
|
JessTrang
Veteran |
29-Aug-2020 20:05
|
||||
|
x 0
x 0 Alert Admin |
Then no point queuing at .022. Queue at .23 because you know where is the value right.
|
||||
| Useful To Me Not Useful To Me | |||||